In this interview we discuss the role of checkpoint inhibitors in advanced lung cancer and treatment strategies when patients progress.
Oncology Vol 31 No 6
In a Significant Percentage of Patients, Neoadjuvant Therapy Yields Equivalent Survival, With Better Quality of Life and Lower Costs
Cytoreductive Surgery Is the Best Way to Affect Survival Outcomes
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Accepts NDA for Mezigdomide Combo in R/R Multiple Myeloma
2
Dostarlimab Yields Sustained Complete Responses in dMMR/MSI-H Rectal Cancer
3
Risvutatug Rezetecan Improves Overall Survival in Relapsed SCLC Trial
4
ADCs in the Frontline: Evolving Approaches in Metastatic TNBC
5